Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers

References

• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39(5):690–7.
   PubMedGoogle Scholar
• Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100(1):143–9.
   PubMedGoogle Scholar
• Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101(7):1559–68.
   PubMedGoogle Scholar
• Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006;12(10):936–43.
   PubMedGoogle Scholar
• Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Collin P. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol 2010;45(9):1063–7.
   PubMedGoogle Scholar
• Lehtinen P, Ashorn M, Iltanen S, Jauhola R, Jauhonen P, Kolho KL, Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis 2010 [Epub ahead of print].
   Google Scholar
• Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13(12):1439–47.
   PubMedGoogle Scholar
• Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006;12(38):6102–8.
   PubMedGoogle Scholar
• Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Incidence of Crohn's disease in four counties in southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31(4):355–61.
   PubMedGoogle Scholar
• Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31(4):362–6.
   PubMedGoogle Scholar
• Perminow G, Frigessi A, Rydning A, Nakstad B, Vatn MH. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol 2006;41(12):1433–9.
   PubMedGoogle Scholar
• Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005–07, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009;44(4):446–56.
   PubMedGoogle Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6.
   PubMedGoogle Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1(8167):514.
   PubMedGoogle Scholar
• Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43(1):29–32.
   PubMedGoogle Scholar
• Daperno M, D'Haens G, Van AG, Baert F, Bulois P, Maunoury V, Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60(4):505–12.
   PubMedGoogle Scholar
• Froslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133(2):412–22.
   PubMedGoogle Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317(26):1625–9.
   PubMedGoogle Scholar
• Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359(9318):1661–5.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55(6):749–53.
   PubMedGoogle Scholar
• Ricanek P, Lothe SM, Szpinda I, Jorde AT, Brackmann S, Perminow G, Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease. Journal of Crohn's and Colitis 2010;4:561–6.
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol 2003;38(2):164–71.
   PubMedGoogle Scholar
• Higgins PD, Schwartz M, Mapili J, Zimmermann EM. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am J Gastroenterol 2005;100(2):355–61.
   PubMedGoogle Scholar
• Hirai F, Matsui T, Aoyagi K, Inoue N, Hibi T, Oshitani N, Validity of activity indices in ulcerative colitis: comparison of clinical and endoscopic indices. Dig Endosc 2010;22(1):39–44.
   PubMedGoogle Scholar
• Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101(6):1274–82.
   PubMedGoogle Scholar
• Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994;35(2):231–5.
   PubMedGoogle Scholar
• Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98(4):811–18.
   PubMedGoogle Scholar
• Vieira A, Fang CB, Rolim EG, Klug WA, Steinwurz F, Rossini LG, Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Res Notes 2009;2:221.
   PubMedGoogle Scholar
• Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14(1):40–6.
   PubMedGoogle Scholar
• Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010;105(1):162–9.
   PubMedGoogle Scholar
• Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997;40(3):328–32.
   PubMedGoogle Scholar
• Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol 2006;41(9):1037–43.
   PubMedGoogle Scholar